These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 23145983)

  • 1. The CRISPRs, they are a-changin': how prokaryotes generate adaptive immunity.
    Westra ER; Swarts DC; Staals RH; Jore MM; Brouns SJ; van der Oost J
    Annu Rev Genet; 2012; 46():311-39. PubMed ID: 23145983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CRISPR/cas system in the development of bacteriophage resistance.
    Szczepankowska A
    Adv Virus Res; 2012; 82():289-338. PubMed ID: 22420856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function and regulation of clustered regularly interspaced short palindromic repeats (CRISPR) / CRISPR associated (Cas) systems.
    Richter C; Chang JT; Fineran PC
    Viruses; 2012 Oct; 4(10):2291-311. PubMed ID: 23202464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicase dissociation and annealing of RNA-DNA hybrids by Escherichia coli Cas3 protein.
    Howard JA; Delmas S; Ivančić-Baće I; Bolt EL
    Biochem J; 2011 Oct; 439(1):85-95. PubMed ID: 21699496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H-NS-mediated repression of CRISPR-based immunity in Escherichia coli K12 can be relieved by the transcription activator LeuO.
    Westra ER; Pul U; Heidrich N; Jore MM; Lundgren M; Stratmann T; Wurm R; Raine A; Mescher M; Van Heereveld L; Mastop M; Wagner EG; Schnetz K; Van Der Oost J; Wagner R; Brouns SJ
    Mol Microbiol; 2010 Sep; 77(6):1380-93. PubMed ID: 20659289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clustered regularly interspaced short palindromic repeats (CRISPRs): the hallmark of an ingenious antiviral defense mechanism in prokaryotes.
    Al-Attar S; Westra ER; van der Oost J; Brouns SJ
    Biol Chem; 2011 Apr; 392(4):277-89. PubMed ID: 21294681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bacterial CRISPR/Cas system as analog of the mammalian adaptive immune system.
    Goren M; Yosef I; Edgar R; Qimron U
    RNA Biol; 2012 May; 9(5):549-54. PubMed ID: 22614830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural plasticity and in vivo activity of Cas1 from the type I-F CRISPR-Cas system.
    Wilkinson ME; Nakatani Y; Staals RH; Kieper SN; Opel-Reading HK; McKenzie RE; Fineran PC; Krause KL
    Biochem J; 2016 Apr; 473(8):1063-72. PubMed ID: 26929403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas and restriction-modification systems are compatible and increase phage resistance.
    Dupuis MÈ; Villion M; Magadán AH; Moineau S
    Nat Commun; 2013; 4():2087. PubMed ID: 23820428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR: new horizons in phage resistance and strain identification.
    Barrangou R; Horvath P
    Annu Rev Food Sci Technol; 2012; 3():143-62. PubMed ID: 22224556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small CRISPR RNAs guide antiviral defense in prokaryotes.
    Brouns SJ; Jore MM; Lundgren M; Westra ER; Slijkhuis RJ; Snijders AP; Dickman MJ; Makarova KS; Koonin EV; van der Oost J
    Science; 2008 Aug; 321(5891):960-4. PubMed ID: 18703739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptation in bacterial CRISPR-Cas immunity can be driven by defective phages.
    Hynes AP; Villion M; Moineau S
    Nat Commun; 2014 Jul; 5():4399. PubMed ID: 25056268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in molecular mechanisms of adaptive immunity mediated by type I-E CRISPR/Cas system--A review].
    Sun D; Qiu J
    Wei Sheng Wu Xue Bao; 2016 Jan; 56(1):1-7. PubMed ID: 27305774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cas3 is a limiting factor for CRISPR-Cas immunity in Escherichia coli cells lacking H-NS.
    Majsec K; Bolt EL; Ivančić-Baće I
    BMC Microbiol; 2016 Mar; 16():28. PubMed ID: 26956996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription profile of Thermus thermophilus CRISPR systems after phage infection.
    Agari Y; Sakamoto K; Tamakoshi M; Oshima T; Kuramitsu S; Shinkai A
    J Mol Biol; 2010 Jan; 395(2):270-81. PubMed ID: 19891975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of E. coli CRISPR-cas promoters and their silencing by H-NS.
    Pul U; Wurm R; Arslan Z; Geissen R; Hofmann N; Wagner R
    Mol Microbiol; 2010 Mar; 75(6):1495-512. PubMed ID: 20132443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation.
    Bhaya D; Davison M; Barrangou R
    Annu Rev Genet; 2011; 45():273-97. PubMed ID: 22060043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling bacterial immune systems: strategies for expression of toxic - but useful - molecules.
    Djordjevic M
    Biosystems; 2013 May; 112(2):139-44. PubMed ID: 23499818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dual function of the CRISPR-Cas system in bacterial antivirus immunity and DNA repair.
    Babu M; Beloglazova N; Flick R; Graham C; Skarina T; Nocek B; Gagarinova A; Pogoutse O; Brown G; Binkowski A; Phanse S; Joachimiak A; Koonin EV; Savchenko A; Emili A; Greenblatt J; Edwards AM; Yakunin AF
    Mol Microbiol; 2011 Jan; 79(2):484-502. PubMed ID: 21219465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR adaptation in Escherichia coli subtypeI-E system.
    Kiro R; Goren MG; Yosef I; Qimron U
    Biochem Soc Trans; 2013 Dec; 41(6):1412-5. PubMed ID: 24256229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.